Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Terminated 2Not yet recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 1Margins of Excision 1Dysplastic Nevus Syndrome 1Disease 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 27pembrolizumab 22Ipilimumab 17Temozolomide 13toripalimab 12Biopsy 10Cyclophosphamide 9Imiquimod 8Dacarbazine 7Blood Specimen Collection 7camrelizumab 6Chemotherapy, Adjuvant 6trametinib 5fludarabine 5dabrafenib 5atezolizumab 5aldesleukin 5Gene Expression Profiling 5Cisplatin 5Aminolevulinic Acid 5fludarabine phosphate 4durvalumab 4binimetinib 4apatinib 4Tomography, Optical Coherence 4Sorafenib 4Photochemotherapy 4Interleukin-2 4Injections 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Dermoscopy × Dermatologic × Clear all
NCT06342297 2024-04-02

Dermatoscopy Guided Resection for Skin Cancer

Region Örebro County

Phase NA Unknown
400 enrolled
Dermatologic

Margins of Excision, Carcinoma, Basal Cell

NCT03362138 2018-09-13

NNCD

Assuta Hospital Systems

Unknown
80 enrolled
Dermatologic

Disease, Dysplastic Nevus Syndrome, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡